环十二烷
化学
特里斯
衍生工具(金融)
对映体过量
组合化学
药物化学
立体化学
对映选择合成
有机化学
催化作用
生物化学
经济
金融经济学
作者
Stuart G. Levy,Vincent Jacques,Kevin Li Zhou,Shirley Kalogeropoulos,Kelly Schumacher,John C. Amedio,J. Scherer,Steven R. Witowski,Richard Lombardy,Karsten J. Koppetsch
摘要
A process for the multigram asymmetric synthesis of the chiral tetraazamacrocycle 2-(R)-2-(4,7,10-tris tert-butylcarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)-pentanedioic acid, 1-tert-butyl ester ((R)-tert-Bu4-DOTAGA, 4) has been devised and demonstrated. The nine-step synthesis features an improved synthesis of 2-(S)-5-oxotetrahydrofuran-2-carboxylic acid, tert-butyl ester 8, the precursor to the novel alkylating agent (S)-5-benzyl 1-tert-butyl 2-(methylsulfonyloxy)pentanedioate 12, which was used to introduce an orthogonally protected chiral glutarate arm to the 1,4,7,10-tetraazacyclododecane (cyclen) nucleus in high optical purity. Cyclen derivative (R)-t-Bu4-DOTAGA, 4, a key intermediate for the manufacture of a magnetic resonance imaging (MRI) candidate, was produced with high chemical (≥95%) and optical (ee ≥ 97%) purity. The process developed was successfully applied to the kilogram-scale cGMP synthesis of (R)-t-Bu4-DOTAGA.
科研通智能强力驱动
Strongly Powered by AbleSci AI